Brown, Lorena E.

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

Jackson, D. C., Lau, Y. F., Le, T., Suhrbier, A., Deliyannis, G., Cheers, C., Smith, C., Zeng, W., & Brown, L. E. (2004) · Proceedings of the National Academy of Sciences

Immunotherapy and Immune Responsesvaccines and immunoinformatics approaches

Cited by 236

Influenza A virus facilitates Streptococcus pneumoniae transmission and disease

Diavatopoulos, D. A., Short, K. R., Price, J. T., Wilksch, J. J., Brown, L. E., Briles, D. E., Strugnell, R. A., & Wijburg, O. L. (2010) · The FASEB Journal

Pneumonia and Respiratory InfectionsInfluenza Virus Research Studies

Cited by 192

A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection

Chua, B. Y., Eriksson, E. M., Brown, L. E., Zeng, W., Gowans, E. J., Torresi, J., & Jackson, D. C. (2008) · Vaccine

Immunotherapy and Immune ResponsesHepatitis C virus research

Cited by 54

Induction of memory cytotoxic T cells to influenza A virus and subsequent viral clearance is not modulated by PB1-F2-dependent inflammasome activation.

Lee, P. (. Y., Bird, N., MacKenzie‐Kludas, C., Mansell, A., Kedzierska, K., Brown, L., & McAuley, J. (2016) · Immunology & Cell Biology

Influenza Virus Research StudiesInflammasome and immune disorders

Cited by 7